IKS Health's Q2 FY26 Earnings Reflect Strong Momentum with 22% Revenue and 60% PAT Growth
Q2 Revenue growth 22% YoY in INR Q2 EBITDA up 43% YoY; 14% QoQ PAT up 60% YoY; 19% QoQ EBITDA Margin 35% PAT Margin 23% Inventurus Knowledge Solutions Limited (NSE: IKS), a technology-enabled healthcare solutions provider, today announced strong growth in Q2 F


